Referanslar

1. McCutcheon RA, Marques TR, Howes OD. Schizophrenia—an overview. JAMA psychiatry. 2020;77(2):201-210. [Crossref]  [PubMed]
2. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. The Lancet. 2022;399(10323):473-486. [Crossref]  [PubMed]
3. Sharma T, Antonova L. Cognitive function in schizophrenia: deficits, functional consequences, and future treatment. Psychiatric Clinics. 2003;26(1):25-40. [Crossref]  [PubMed]
4. van der Gaag M, Hoffman T, Remijsen M, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res. Jul 2006;85(1-3):280-7. [Crossref]  [PubMed]
5. Rodriguez-Jimenez R, Bagney A, Mezquita L, et al. Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia. Schizophr Res. Jan 2013;143(1):77-83. [Crossref]  [PubMed]
6. Moura BM, Van Rooijen G, Schirmbeck F, et al. A network of psychopathological, cognitive, and motor symptoms in schizophrenia spectrum disorders. Schizophrenia bulletin.2021;47(4):915-926. [Crossref]  [PubMed]  [PMC]
7. Browne J, Penn DL, Raykov T, et al. Social cognition in schizophrenia: Factor structure of emotion processing and theory of mind. Psychiatry Res. Aug 30 2016;242:150-156. [Crossref]  [PubMed]  [PMC]
8. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. Jan 2011;35(3):573-88. [Crossref]  [PubMed]
9. Andreasen NC, Nopoulos P, O’Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. Oct 1 1999;46(7):908-20. [Crossref]  [PubMed]
10. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. Dec 15 2004;72(1):29-39. [Crossref]  [PubMed]
11. Burton CZ, Vella L, Harvey PD, Patterson TL, Heaton RK, Twamley EW. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophr Res. May 2013;146(1-3):244-8. [Crossref]  [PubMed]  [PMC]
12. Keefe RS, Bilder RM, Harvey PD, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006;31(9):2033-2046. [Crossref]  [PubMed]
13. Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry. Nov 1 2008;64(9):823-7. [Crossref]  [PubMed]  [PMC]
14. Goldberg J, Stahl S. Biliş. In: Aslan EA, Güleryüz FÇ, eds. Pratik Psikofarmakoloji Kanıta Dayalı Araştırmalardan Klinik Uygulamalara Tıp Kitabı. İstanbul Tıp Kitabevi; 2024. [Crossref]
15. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of general psychiatry. 2007;64(5):532-542. [Crossref]  [PubMed]
16. Knowles EE, David AS, Reichenberg A. Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry. Jul 2010;167(7):828-35. [Crossref]  [PubMed]
17. Fatouros-Bergman H, Cervenka S, Flyckt L, Edman G, Farde L. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia. Schizophr Res. Sep 2014;158(13):156-62. [Crossref]  [PubMed]
18. de Gracia Dominguez M, Viechtbauer W, Simons CJ, van Os J, Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Schizophrenia Research. 2008;102(1-3):118. [Crossref]
19. Akdede BB, Atbaoğlu EC. Şizofreni ve Bilişsel İşlevler. In: Soygür H, Alptekin K, Atbaşoğlu EC, Herken H, eds. Şizofreni ve Diğer Psikotik Bozukluklar. Türkiye Psikiyatri Derneği Yayınları; 2007:236-249.
20. Harvey PD, Docherty NM, Serper MR, Rasmussen M. Cognitive deficits and thought disorder: II. An 8-month followup study. Schizophrenia Bulletin. 1990;16(1):147-156. [Crossref]  [PubMed]
21. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry. Feb 1990;47(2):181-8. [Crossref]  [PubMed]
22. Kayahan B, Öztürk Ö, Veznedaroğlu B. Şizofrenide Biliş- sel Bozukluklar. Turkiye Klinikleri Journal of Psychiatry. 2004;5(2):122-131.
23. Downs J, Dean H, Lechler S, et al. Negative symptoms in early-onset psychosis and their association with antipsychotic treatment failure. Schizophrenia bulletin. 2019;45(1):69-79. [Crossref]  [PubMed]  [PMC]
24. Frith C. The cognitive neuropsychology of schizophrenia. Int J Psychol. 2000;35(3-4):272-273. [Crossref]  [PubMed]
25. Knowles EE, Weiser M, David AS, Glahn DC, Davidson M, Reichenberg A. The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together. Biol Psychiatry. Dec 1 2015;78(11):786-93. [Crossref]  [PubMed]  [PMC]
26. Harvey PD, Penn D. Social cognition: the key factor predicting social outcome in people with schizophrenia? Psychiatry (Edgmont). Feb 2010;7(2):41-4.
27. Kohler CG, Walker JB, Martin EA, Healey KM, Moberg PJ. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophrenia bulletin. 2010;36(5):1009-1019. [Crossref]  [PubMed]  [PMC]
28. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. Feb 2001;31(2):189-95. [Crossref]  [PubMed]
29. Balikci K, Aydin O, Sonmez I, Danaci AE. The examination of the relationship between the blood oxytocin level and attachment styles among mothers of schizophrenia patients/ Sizofreni hastalarinin annelerinde baglanma bicimi ile kan oksitosin duzeyi arasindaki iliskinin incelenmesi. Anadolu Psikiyatri Dergisi. 2018;19(6):531-537. [Crossref]  [PubMed]
30. Aydın O, Lysaker PH, Balıkçı K, Ünal-Aydın P, Esen-Danacı A. Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia. Psychiatry Res. Dec 2018;270:1010-1016. [Crossref]  [PubMed]
31. Tas C, Danaci AE, Cubukcuoglu Z, Brüne M. Impact of family involvement on social cognition training in clinically stable outpatients with schizophrenia—a randomized pilot study. Psychiatry research. 2012;195(1-2):32-38. [Crossref]  [PubMed]
32. Joyce EM, Roiser JP. Cognitive heterogeneity in schizophrenia. Curr Opin Psychiatry. May 2007;20(3):268-72. [Crossref]  [PubMed]  [PMC]
33. Catalan A, Radua J, McCutcheon R, et al. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis. Translational psychiatry. 2022;12(1):198. [Crossref]  [PubMed]  [PMC]
34. Shin YS, Kim SN, Shin NY, et al. Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients. PLoS One. 2013;8(11):e78354. [Crossref]  [PubMed]  [PMC]
35. MacCabe JH, Wicks S, Löfving S, et al. Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males. JAMA Psychiatry. Mar 2013;70(3):261-70. [Crossref]  [PubMed]
36. Sheffield JM, Karcher NR, Barch DM. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective. Neuropsychol Rev. Dec 2018;28(4):509-533. [Crossref]  [PubMed]  [PMC]
37. Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology. Nov 2005;19(6):778-86. [Crossref]  [PubMed]
38. Catalan A, Salazar de Pablo G, Aymerich C, et al. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry. Jun 16 2021;78(8):859-67. [Crossref]  [PubMed]  [PMC]
39. Salazar de Pablo G, Radua J, Pereira J, et al. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis. JAMA Psychiatry. Sep 1 2021;78(9):970-978. [Crossref]  [PubMed]  [PMC]
40. Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophrenia bulletin. 2014;40(4):744-755. [Crossref]  [PubMed]  [PMC]
41. Hedges EP, See C, Si S, McGuire P, Dickson H, Kempton MJ. Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis. Psychological Medicine. 2022;52(11):2009-2016. [Crossref]  [PubMed]  [PMC]
42. Watson AJ, Harrison L, Preti A, Wykes T, Cella M. Cognitive trajectories following onset of psychosis: a meta-analysis. The British journal of psychiatry. 2022;221(6):714-721. [Crossref]  [PubMed]
43. Bonner-Jackson A, Grossman LS, Harrow M, Rosen C. Neurocognition in schizophrenia: a 20-year multi-followup of the course of processing speed and stored knowledge. Compr Psychiatry. Sep-Oct 2010;51(5):471-9. [Crossref]  [PubMed]  [PMC]
44. Fett AJ, Velthorst E, Reichenberg A, et al. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project. JAMA Psychiatry. Apr 1 2020;77(4):387-396. [Crossref]  [PubMed]  [PMC]
45. Zanelli J, Mollon J, Sandin S, et al. Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode. Am J Psychiatry. Oct 1 2019;176(10):811819. [Crossref]  [PubMed]
46. Velthorst E, Mollon J, Murray RM, et al. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Mol Psychiatry. Aug 2021;26(8):4529-4543. [Crossref]  [PubMed]
47. Richmond-Rakerd LS, D’Souza S, Milne BJ, Caspi A, Moffitt TE. Longitudinal Associations of Mental Disorders With Dementia: 30-Year Analysis of 1.7 Million New Zealand Citizens. JAMA Psychiatry. Apr 1 2022;79(4):333-340. [Crossref]  [PubMed]  [PMC]
48. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. Oct 2005;162(10):1785-804. [Crossref]  [PubMed]
49. Reichenberg A, Harvey PD, Bowie CR, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia bulletin. 2009;35(5):1022-1029. [Crossref]  [PubMed]  [PMC]
50. Li W, Zhou FC, Zhang L, et al. Comparison of cognitive dysfunction between schizophrenia and bipolar disorder patients: A meta-analysis of comparative studies. J Affect Disord. Sep 1 2020;274:652-661. [Crossref]  [PubMed]
51. Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;11:3111-25. [Crossref]  [PubMed]  [PMC]
52. Barch DM, Bustillo J, Gaebel W, et al. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res. Oct 2013;150(1):15-20. [Crossref]  [PubMed]
53. Trotta A, Murray RM, MacCabe JH. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol Med. Jan 2015;45(2):381-94. [Crossref]  [PubMed]
54. Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des. 2012;18(4):351-7. [Crossref]  [PubMed]
55. Glenthøj LB, Mariegaard L, Kristensen TD, Wenneberg C, Medalia A, Nordentoft M. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning. NPJ Schizophr. Nov 13 2020;6(1):31. [Crossref]  [PubMed]  [PMC]
56. Paudel S, Coman D, Freudenreich O. Subjective experience of cognitive difficulties as an important attribute of quality of life among individuals with schizophrenia spectrum disorders. Schizophr Res. Jan 2020;215:476-478. [Crossref]  [PubMed]
57. Raffard S, Lebrun C, Bayard S, Macgregor A, Capdevielle D. Self-Awareness Deficits of Cognitive Impairment in Individuals With Schizophrenia. Really? Front Psychiatry. 2020;11:731.
58. Homayoun S, Nadeau-Marcotte F, Luck D, Stip E. Subjective and objective cognitive dysfunction in schizophrenia–is there a link? Frontiers in Psychology. 2011;2:148. [Crossref]  [PubMed]  [PMC]
59. Santarelli V, Marucci C, Collazzoni A, et al. Could the severity of symptoms of schizophrenia affect ability of self-appraisal of cognitive deficits in patients with schizophrenia? Lack of insight as a mediator between the two domains. European Archives of Psychiatry and Clinical Neuroscience. 2020;270:723-728. [Crossref]  [PubMed]